Company intelligence / Profile preview

Beijing Fukangren Biopharmaceutical

Beijing, Beijing, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Beijing Fukangren Biopharmaceutical is a Chinese pharmaceutical/biotech company known for its production of biologics and recombinant protein therapies, including essential drugs for diabetes (like recombinant human insulin) and hepatitis B. The company has a commercial footprint in China and an established portfolio of approved and marketed products in metabolic and infectious diseases. It is not a drug discovery platform company but focuses on biomanufacturing and commercialization.

Modalities: Small moleculeRecombinant proteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on Beijing Fukangren Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Fukangren Biopharmaceutical.

Explore the full profile